DuPont Archives - CFO

IFF Wins DuPont’s Nutrition and Biosciences Unit

IFF Wins DuPont’s Nutrition and Biosciences Unit

The $26.2 billion deal will create a new company valued at more than $45 billion.

By Lauren Muskett | December 17, 2019

CFOs Find a New Role as Legal Strategists

Risk & Compliance

CFOs Find a New Role as Legal Strategists

As companies take a profit-driven approach to litigation, CFOs are part of conversations about leveraging legal assets, such as through litigation finance.

By Reed Oslan | November 7, 2018

Dow Chemical to Cut 2,500 Jobs

Dow Chemical to Cut 2,500 Jobs

The company will take a charge of up to $460 million in the second quarter of 2016 for asset impairments, severance, and other costs.

By Katie Kuehner-Hebert | June 28, 2016

DuPont Layoffs Dent Delaware’s Credit Outlook

DuPont Layoffs Dent Delaware’s Credit Outlook

Moody's says the job cuts will reduce DuPont's Delaware workforce by a “significant” 24% and are a credit negative for the Wilmington area.

By Matthew Heller | January 19, 2016

DuPont to Cut 1,700 Jobs in Delaware

DuPont to Cut 1,700 Jobs in Delaware

The company says the layoffs of 28% of its home state workforce reflect an "urgent need" to reduce corporate overhead costs.

By Matthew Heller | December 30, 2015

Dow, DuPont to Create $130B Chemical Giant

Dow, DuPont to Create $130B Chemical Giant

A mega-merger of equals combines two of corporate America's oldest companies, which have been struggling with falling commodity prices.

By Katie Kuehner-Hebert | December 11, 2015

Interim CEOs Are Prone to Inflating Earnings

Risk & Compliance

Interim CEOs Are Prone to Inflating Earnings

Not only that, they're more likely to be promoted to the top job permanently if they do.

By David McCann | November 18, 2015

DuPont Shareholders Reject Dissident Board Slate

DuPont Shareholders Reject Dissident Board Slate

Election of all 12 of DuPont's director nominees is a blow to activist investor Nelson Peltz and his hedge fund.

By Katie Kuehner-Hebert | May 13, 2015

Top Lawyer Changes Tune on Activist Investors

Top Lawyer Changes Tune on Activist Investors

Martin Lipton advises companies to meet with activists and avoid "drawn out" proxy battles.

By Matthew Heller | April 30, 2015

Currency Surprises Hammer Earnings

Currency Surprises Hammer Earnings

A strong U.S. dollar and other currency swings are revealing companies' shortcomings in the area of identifying and quantifying foreign-exchange exposures.

By Katie Kuehner-Hebert | March 17, 2015

Big Business Joins U.S. Fight Against HFC Gases

Big Business Joins U.S. Fight Against HFC Gases

Dupont, Honeywell and others reach agreement with the Obama administration to reduce their use of hydrofluorocarbons.

By Matthew Heller | September 17, 2014

Bringing Discipline to Your Sustainability Initiatives

Risk & Compliance

Bringing Discipline to Your Sustainability Initiatives

Many companies have more sustainability initiatives than they can possibly manage. Here’s how to get them under control.

By Sheila Bonini and Steven Swartz | August 22, 2014

The Reinvention of an Industrial Titan

The Reinvention of an Industrial Titan

DuPont is again remaking itself, with a shifting R&D strategy and a pile of acquisitions and divestitures. The CFO gives his take on the transformation.

By David McCann | November 22, 2013

Major Flux for Retiree Health Care

Major Flux for Retiree Health Care

IBM and Time Warner are the latest to say they’ll send ex-workers to private health-insurance exchanges. Companies making this move and their retirees could both be better off.

By David McCann | September 10, 2013

The Story Trumps the Data

The Story Trumps the Data

Big data promises to revolutionize human-capital management, but it's the stories behind the data that will endure. We just have to find them.

By John Boudreau | May 24, 2013